Tirzepatide reduced sleep apnea events and improved weight loss, reshaping treatment for nighttime breathing disorders.
The Australia’s Therapeutic Goods Administration (TGA) has approved the use of tirzepatide, a powerful weight-loss injection for the treatment of obstructive sleep apnoea (OSA) in adults living with ...
Health Canada has approved an injection medication to treat severe obstructive sleep apnea in adults with obesity.
(urbazon/E+/Getty Images) Nearly 1 billion people across the world are affected by sleep apnea – and that's not including the people sleeping next to those with the disorder. The hallmark of ...
Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your breathing temporarily stops while you sleep. Depending on the severity of ...
Share on Pinterest New research finds that the GLP-1 drug tirzepatide may help lessen sleep apnea symptoms. Jackyenjoyphotography/Getty Images The obesity and diabetes medication tirzepatide (Mounjaro ...
Liraglutide and tirzepatide are two common glucagon-like peptide-1 (GLP-1) receptor agonist medications. With so many ...
Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your breathing temporarily stops while you sleep. Depending on the severity of ...
By Dennis Thompson HealthDay ReporterWEDNESDAY, May 20, 2026 (HealthDay News) — Some people with sleep apnea might be able to ...
Zepbound, a popular weight loss drug from Eli Lilly, may help people with sleep apnea. Based on recent findings, Eli Lilly plans to submit the material to the U.S. Food and Drug Administration to ...
This study aimed to analyze the effect of acute aerobic exercise at different times of the day on respiratory sleep parameters, blood pressure (BP), and cardiac autonomic modulation in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results